Cargando…

Dolutegravir-associated resistance mutations after first-line treatment failure in Brazil

BACKGROUND: Since January 2017, the recommended first-line antiretroviral regimen in Brazil is the fixed-dose combination of tenofovir plus lamivudine with dolutegravir (TL + D). According to the literature, integrase resistance-associated mutations (INRAMs) are rarely found upon virologic failure t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diaz, Ricardo Sobhie, Hunter, James R., Camargo, Michelle, Dias, Danilo, Galinskas, Juliana, Nassar, Isabela, de Lima, Isaac Barbosa, Caldeira, Debora Bellini, Sucupira, Maria Cecilia, Schechter, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210384/ https://www.ncbi.nlm.nih.gov/pubmed/37226112 http://dx.doi.org/10.1186/s12879-023-08288-8

Ejemplares similares

High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil
por: Grinberg, Gorki, et al.
Publicado: (2015)

Re-emergence of mayaro virus and coinfection with chikungunya during an outbreak in the state of Tocantins/Brazil
por: dos Santos Souza Marinho, Robson, et al.
Publicado: (2022)

Uniquely altered transcripts are associated with immune preservation in HIV infection
por: Zanoni, Michelle, et al.
Publicado: (2017)

Analysis of HIV-1 Protease Gene Reveals Frequent Multiple Infections Followed by Recombination among Drug Treated Individuals Living in São Paulo and Santos, Brazil
por: Nunes, Edsel Renata De Morais, et al.
Publicado: (2014)

Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294
por: Samer, Sadia, et al.
Publicado: (2020)

Could well-established, widely available, and simple laboratory techniques explain a laboratory origin of SARS-CoV-2?
por: Lloyd Jr, Robert M., et al.
Publicado: (2023)

The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use
por: Diaz, Ricardo Sobhie, et al.
Publicado: (2015)

HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country
por: Nutini, Mariana Fernanda Rodrigues, et al.
Publicado: (2020)

Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy
por: Giron, Leila Bertoni, et al.
Publicado: (2019)

Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]
por: Blum, Vinicius Fontanesi, et al.
Publicado: (2021)

Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.
por: Blum, Vinicius Fontanesi, et al.
Publicado: (2021)

Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
por: Hunter, James R., et al.
Publicado: (2021)

Antiretroviral Drug-Resistance Mutations on the Gag Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure
por: Hunter, James R., et al.
Publicado: (2022)

Effects of Carbon Nanomaterials and Aloe vera on Melanomas—Where Are We? Recent Updates
por: de Carvalho Lima, Elidamar Nunes, et al.
Publicado: (2022)

Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial
por: de Almeida Baptista, Marcella Vassão, et al.
Publicado: (2022)

Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment
por: Scarpelini, Bruno, et al.
Publicado: (2016)

Correction: Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment
por: Scarpellini, Bruno, et al.
Publicado: (2017)

Two cases of neural tube defects with dolutegravir use at conception in south Brazil
por: Kreitchmann, Regis, et al.
Publicado: (2021)

Study of Viral Photoinactivation by UV-C Light and Photosensitizer Using a Pseudotyped Model
por: Sadraeian, Mohammad, et al.
Publicado: (2022)

Analysis of protease treatment-associated mutations in a group of HIV-1 subtype F infected individuals with two sequences obtained in different time points
por: Oliveros, Márcia Perez Resende, et al.
Publicado: (2010)

Comparison among the BED capture enzyme immunoassay test and AxSYM avidity index assay for determining recent HIV infection and incidence in two Voluntary Counselling and Testing Centres in Northeast Brazil
por: Salustiano, Daniela Medeiros, et al.
Publicado: (2014)

The promise of paediatric dolutegravir
por: Golin, Rachel, et al.
Publicado: (2021)

Environmental Changes and the Impact on the Human Infections by Dengue, Chikungunya and Zika Viruses in Northern Brazil, 2010–2019
por: Marinho, Robson dos Santos Souza, et al.
Publicado: (2022)

Is Hepatitis Delta infections important in Brazil?
por: Cicero, Maira Ferreira, et al.
Publicado: (2016)

Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil
por: Ristic, Natalia, et al.
Publicado: (2011)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Correction: Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil
por: Ristic, Natalia, et al.
Publicado: (2011)

Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil
por: Mota, Magaly Lima, et al.
Publicado: (2021)

Faster HIV-1 Disease Progression among Brazilian Individuals Recently Infected with CXCR4-Utilizing Strains
por: Sucupira, Maria Cecilia Araripe, et al.
Publicado: (2012)

High levels of polymorphisms related to raltegravir resistance among raltegravir-naïve individuals in Brazil
por: Pena, N Mantovani, et al.
Publicado: (2010)

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? A case report
por: Mulindwa, Frank, et al.
Publicado: (2023)

Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
por: Chapola, John C., et al.
Publicado: (2023)

Should dolutegravir always be withheld in people with HIV on dolutegravir with incident diabetes mellitus? a case report
por: Mulindwa, Frank, et al.
Publicado: (2023)

Epigenetic Modulations in Activated Cells Early after HIV-1 Infection and Their Possible Functional Consequences
por: Maricato, Juliana T., et al.
Publicado: (2015)

Prevalence, Incidence Density, and Genotype Distribution of GB Virus C Infection in a Cohort of Recently HIV-1-Infected Subjects in Sao Paulo, Brazil
por: Giret, Maria Teresa M., et al.
Publicado: (2011)

Detection of human feces pecovirus in newly diagnosed HIV patients in Brazil
por: Sanz Duro, Rodrigo Lopes, et al.
Publicado: (2022)

Nurse Navigator: development of a program for Brazil
por: Pautasso, Fernanda Felipe, et al.
Publicado: (2020)

Seroprevalence of hepatitis E virus in chronic hepatitis C in Brazil
por: Bricks, Guilherme, et al.
Publicado: (2018)

Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir
por: Johnson, Mark, et al.
Publicado: (2014)

The role of dolutegravir in the management of HIV infection
por: Miller, Misty M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r59m2tidm7ode2tqk4397oij2e